Andy Molnar, CEO of the Digital Therapeutics Alliance, has been selected as an industry representative for the FDA's Digital Health Advisory Committee (DHAC).
The FDA established the DHAC to ensure safe and effective regulation of digital health offerings, including AI and machine learning, virtual reality, cybersecurity, patient-generated health data and wearable technologies.
The committee...
The Access to Prescription Digital Therapeutics Act, initially introduced in the U.S. Senate in 2022 and reintroduced in March of this year, aims to amend the Social Security Act to provide Medicare and Medicaid coverage and reimbursement for prescription digital therapeutics.
Jennifer Mathieu, senior vice president of professional and government affairs at the Academy of Managed Care Pharmacy (...
Italy-based healthcare agency, consultancy and digital health group, Healthware, and the Digital Therapeutics Alliance, a nonprofit organization based in Virginia that provides thought leadership and education to advance digital therapeutic adoption, today announced the release of a report outlining policy pathways for digital health adoption in Europe.
Alberta Spreafico, managing director of...
Since Pear Therapeutics, one of the earliest digital therapeutic companies, declared bankruptcy in April, there's been discussion surrounding the state of investments in digital therapeutics, challenges that exist around standards of care, barriers to adoption and how to achieve success in the sector.
Andy Molnar, CEO of the Digital Therapeutics Alliance, a nonprofit organization that provides...
New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it's new technology, and the wrong reimbursement model could tamper innovation and increase patient costs.
The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March...
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today, in a session moderated by YourCoach Health chairman and COO Eugene Borukhovich.
“Once a...
Easy access to (temporarily) free counseling. Consumer telehealth and mail-order prescription services Hims and Hers are dipping into the mental health wellness space. The brands kicked off new anonymized group therapy and guided meditation offerings yesterday, with the therapy sessions led by a licensed mental health practitioner.
The group sessions are currently being offered free of charge in...
The Digital Therapeutics Alliance, an industry group advocating for the adoption and understanding of evidence-based digital health treatments, has named its new Board of Directors. Representing handful of different digital therapeutics stakeholders, those named are set to hold their positions for a two-year period.
Along with Megan Coder, the group’s executive director, the board consists of:...
The precise definition of digital therapeutics has been a hot topic as the new technology category has been discussed and debated in event sessions and articles over the last few years. Now the Digital Therapeutics Alliance, a consortium of industry stakeholders, is hoping to put that to rest with an official definition, released this week in a whitepaper.
The definition reads as follows:
"...
From syringes to workflow management systems, healthcare is no stranger to adopting new technologies into standard care. As digital and connected technologies continue to stake their claim in the industry, the last few years have seen the rise of a new type of health technology product — one that promises measurable health outcomes validated by traditional clinical trials.
“You had a little...
